Influence of hirudin on the thrombin-induced release of tissue plasminogen activator from isolated perfused pig ear
Klöcking, H.P.; Hoffmann, A.; Markwardt, F.
Folia Haematologica 115(1-2): 110-112
1988
ISSN/ISBN: 0323-4347 PMID: 2459003 Document Number: 325136
Document emailed within 1 workday
Related Documents
Matsubara, F.; Sueishi, K.; Ishii, Y.; Tanaka, K. 1985: Release of plasminogen activator from isolated perfused dog heart Thrombosis and Haemostasis 53(1): 126-129Klöcking, H.P.; Hoffmann, A. 1989: Mechanisms of thrombin-induced plasminogen activator release Folia Haematologica 116(6): 895-899
Tranquille, N.; Emeis, J.J. 1990: The simultaneous acute release of tissue-type plasminogen activator and von Willebrand factor in the perfused rat hindleg region Thrombosis and Haemostasis 63(3): 454-458
Tanswell, P.; Heinzel, G.; Greischel, A.; Krause, J. 1990: Nonlinear pharmacokinetics of tissue-type plasminogen activator in three animal species and isolated perfused rat liver Journal of Pharmacology and Experimental Therapeutics 255(1): 318-324
Kobayashi, Y.; Fukuo, Y.; Shibuya, T.; Terashi, A. 1990: The correlation between the activity of tissue plasminogen activator (TPA), levels of tissue plasminogen activator inhibitor (PAI-1) antigen and serum lipids in healthy subjects Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 27(5): 578-583
Chen, L.; Nichols, W.W.; Mattsson, C.; Teger-Nilsson, A.C.; Saldeen, T.G.; Mehta, J.L. 1996: Inogatran, a novel direct low molecular weight thrombin inhibitor, given with, but not after, tissue-plasminogen activator, improves thrombolysis Journal of Pharmacology and Experimental Therapeutics 277(3): 1276-1283
Buczko, W.; Iacoviello, L.; De Curtis, A.; Amore, C.; Donati, M.B. 1991: Aging and tissue plasminogen activator release Thrombosis and Haemostasis 66(6): 745
Hayakawa, Y.; Tazawa, S.; Ishikawa, T.; Niiya, K.; Sakuragawa, N. 1995: Transcriptional regulation of tissue- and urokinase-type plasminogen activator genes by thrombin in human fetal lung fibroblasts Thrombosis and Haemostasis 74(2): 704-710
Habib, S.S.; Abdel Gader, A.G.M.; Kurdi, M.I.; Suriya, M.O.; Al Aseri, Z. 2012: Tissue plasminogen activator and plasminogen activator inhibitor-1 levels in patients with acute myocardial infarction and unstable angina JPMA. Journal of the Pakistan Medical Association 62(7): 681-685
Han, X.M.; Chen, Z.Q.; Mao, H.M. 1990: Determination of plasma tissue type plasminogen activator and plasminogen activator inhibitor activity in patients with ischemic stroke Zhonghua Nei Ke Za Zhi 29(9): 544-546; 575-576
Yamada, R.; Yamada, S.; Ishii, A.; Tane, S. 1993: Evaluation of tissue plasminogen activator and plasminogen activator inhibitor-1 in blood obtained from patients of idiopathic central serous chorioretinopathy Nippon Ganka Gakkai Zasshi 97(8): 955-960
De Moerloose, P.; Mermillod, N.; Amiral, J.; Reber, G. 1998: Thrombomodulin levels during normal pregnancy, at delivery and in the postpartum: comparison with tissue-type plasminogen activator and plasminogen activator inhibitor-1 Thrombosis and Haemostasis 79(3): 554-556
Fukao, H.; Yamamoto, K.; Matsuo, O. 1991: Levels of tissue-type plasminogen activator and plasminogen activator inhibitor 1 in disseminated intravascular coagulation syndrome Rinsho Byori. Japanese Journal of Clinical Pathology 39(7): 720-726
Shiba, E.; Kobayashi, T.; Yayoi, E.; Takatsuka, Y.; Koyama, H.; Takai, S.; Mori, T. 1992: Measurement of plasminogen activator and plasminogen activator inhibitor in breast cancer tissue: preliminary report Nihon Geka Gakkai Zasshi 93(1): 109
Wallnöfer, A.E.; van Griensven, J.M.; Schoemaker, H.C.; Cohen, A.F.; Lambert, W.; Kluft, C.; Meijer, P.; Kooistra, T. 1993: Effect of isotretinoin on endogenous tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1) in humans Thrombosis and Haemostasis 70(6): 1005-1008
Nelles, L.; Lijnen, H.R.; Van Nuffelen, A.; Demarsin, E.; Collen, D. 1990: Characterization of domain deletion and/or duplication mutants of a recombinant chimera of tissue-type plasminogen activator and urokinase-type plasminogen activator (rt-PA/u-PA) Thrombosis and Haemostasis 64(1): 53-60
Fujii, S.; Lucore, C.L.; Hopkins, W.E.; Billadello, J.J.; Sobel, B.E. 1990: Induction of synthesis of plasminogen activator inhibitor type-1 by tissue-type plasminogen activator in human hepatic and endothelial cells Thrombosis and Haemostasis 64(3): 412-419
Grant, M.B.; Guay, C.; Lottenberg, R. 1988: Desmopressin stimulates parallel norepinephrine and tissue plasminogen activator release in normal subjects and patients with diabetes mellitus Thrombosis and Haemostasis 59(2): 269-272
Ladenvall, P.; Wall, U.; Jern, S.; Jern, C. 2000: Identification of eight novel single-nucleotide polymorphisms at human tissue-type plasminogen activator (t-PA) locus: association with vascular t-PA release in vivo Thrombosis and Haemostasis 84(2): 150-155
Rość, D.; Drewniak, W.; Kotschy, M.; Graczykowska-Koczorowska, A.; Raukuć, D. 1997: Plasminogen tissue activator and plasminogen tissue inhibitor in type Ii diabetes Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 2(7): 24-25